Cancer Pain Management Market: Outlook, Competitive Landscape and Forecasts to 2025

Cancer Pain Management Market: Overview

The global cancer pain management market is envisaged to gain a telling impetus while riding on the moderate to severe pattern of pain experienced by patients worldwide. Nearly a 70.0% of cancer patients could suffer from chronic pain because of spinal cord injuries, 28.0% due to multiple sclerosis, and 8.0% on account of stroke on a global platform. Besides this, an above 75.0% of the patients are expected to complain of a gradual surge in pain with the progression of the disease. Increase in the count of patients experiencing such pain could put a positive effect on the growth of the market.

With elevating research and development focus, there could be a range of drugs in the pipeline. This is anticipated to bode well for the global cancer pain management market as more drugs could mean a rise in demand.

Download PDF Brochure of Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26897

From the geographical perspective, the global cancer pain management market is prognosticated to be segregated into key regions, out of which, North America could take a leading position. Better healthcare spending, improved healthcare infrastructure, and presence of leading players are some of the top reasons that the region is predicted to outclass other geographical segments of the market. However, Asia Pacific could make its presence known for cancer pain management on the back of enhanced healthcare services provided to patients and key countries such as India, Brazil, and China exhibiting multiplied investments by their governments. Growing awareness about cancer and its pain management could also contribute to the growth of Asia Pacific.

Pain is an unpleasant emotional, subjective, and sensory experience due to the actual or potential damage caused to cells or tissues of the patients. Pain is the most common symptom in various manifestations that lead patients to seek medical assistance or advice. Cancer is associated with several well-defined acute as well as chronic pain syndromes. Cancer is a complex and potentially fatal disease that is primarily caused through environmental factors resulting into gene mutations affecting critical cell-regulatory proteins. Such changes trigger aberrant cell behavior leading to uncontrolled proliferation of cells (tumor formation) and subsequent destruction of surrounding normal tissues. Tumors are either benign or malignant, while the malignant tumors are characterized by rapid growth, invasiveness, and potential to colonize in distant organs. These tumors exert pressure by pressing on nerves, bones, and other parts of the body causing pain. Cancer pain is also experienced during active cancer therapy and primarily during the advanced stages of cancer.

Request to View TOC of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=26897

The rising prevalence of cancer across the globe is driving the global cancer diagnostics market. According to the International Agency for Research on Cancer, there were 14.1 million new cases of cancer and 8.2 million deaths recorded globally in 2012. Based on the above statistical information, the World Health Organization (WHO) estimated that by 2025, 19.3 million new cases are expected to occur each year. Rising incidences of cancer and increasing healthcare spending is anticipated to aid the global cancer pain management market. Moreover, the Patient Protection Act and Affordable Care Act amended on March 30, 2010, by the Health Care and Education Reconciliation Act, enhancing the insurance access to more than 25 million U.S. citizens, is eventually estimated to support the growth of cancer pain management.

The pain management methods for cancer used currently, include medication or drugs, nerve blocks, oral morphine therapy, fentanyl patches, and medical systems or devices. Opioids are considered to be the most effective way of pain management, while combined pain management therapies and medication are more effective. The global market for cancer pain management is projected to expand significantly due to advances in technology for better alternatives for pain management and favorable government initiatives and funding. The alarming rise in the rate of cancer prevalence compels healthcare providers to rethink of their goals of treating cancer and also focus on pain management, which is likely to require cancer pain management methods that are specific, efficient, and sensitive. The cancer pain management market can be segmented into treatment type, disease indication, and regions, which is as follows:

By treatment type, the cancer pain management market can be segmented into:

  • Medications
    • Opioids/Narcotics
      • Morphine
      • Fentanyl
      • Others
    • Non-Opioids
      • Acetaminophen
      • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • Nerve Blocks
  • Devices or Systems
    • Electrical Stimulation Devices
      • Transcutaneous Electrical Nerve Stimulation (TENS) Devices
      • Neuromuscular Electrical Stimulation (NMES/EMS) Devices
      • Others (Electrotherapy Devices, Combination Devices, etc.)
    • Analgesic Infusion Pumps
      • Intrathecal Infusion Pumps
      • External Infusion Pumps
    • Neurostimulation Devices
      • Spinal Cord Stimulation (SCS) Devices
      • Deep Brain Stimulation Devices
      • Others
    • Radiofrequency Ablation Devices

By disease indication, the cancer pain management market can be segmented into:

  • Lung Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Blood Cancer
  • Others

Request to View Discount –

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=26897

In terms of regions, the cancer pain management market can be into Asia Pacific (APAC), Europe, Middle East & Africa (MEA), North America (NA), and Latin America (LA). Key players operating in the cancer pain management market include Abbott, Boston Scientific Corporation, Baxter, Medtronic plc., and Olympus. Intense competition is driving acquisition and in-licensing agreements, as companies are striving to expand and diversify their product pipeline. Strategic partnership and alliances are commonplace, as companies are aiming to synergize their programs and develop combination pain management therapies.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Leave a Reply